Facile Synthesis, In silico Studies, and Biological Assessment of Novel Pyrazolo[3,4-b]pyridine Congeners | ||||
| Egyptian Journal of Chemistry | ||||
| Articles in Press, Accepted Manuscript, Available Online from 03 May 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2024.280985.9546 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ibrahim F. Nassar   1; Adel A.-H. Abdel-Rahman 2; esraa m El-Nemr3; Mohamed A Said4; mohamed G Abouelenein3
| ||||
| 1Ain Shams University | ||||
| 2Chemistry Department, Faculty of Science, Menoufia University, Shebin El-Koam, EGYPT. | ||||
| 3chemistry department, faculty of science, menofia university | ||||
| 4Pharmaceutical Chemistry department, Faculty of Pharmacy, Egyptian Russian University | ||||
| Abstract | ||||
| The present work depicts synthesizing an innovative sequence of polyfunctionalized Pyrazolo[3,4-b]pyridine congeners 2-12 and assessed for antimicrobial, antitumor, telomerase inhibition, and anti-hepatitis B efficacies applying an array of techniques. Fortunately, most of the compounds demonstrated auspicious bio efficiencies. Additionally, in silico simulation was executed for determining the synthetic Pyrazolo[3,4-b]pyridines anticipated mode of action. Compounds 4, 5, and 6 were picked as the most potent and efficient candidates versus the telomerase enzyme [PDB id: 2B2A]. The consequences exposed that compound 5 is the extremely credible operative in contradiction of telomerase enzyme as it disclosed the best binding score and interaction pose. These initial outcomes may improve in introducing more research strategies converged on pyrazolo[3,4-b]pyridines, exclusively those with anticipated bioefficacy, ultimate ADMET parameters, and constructive prospects. | ||||
| Keywords | ||||
| Telomerase; Molecular docking; Pyridine; ADMET; Antitumor; Antimicrobial; Anti-hepatitis B | ||||
|
Statistics Article View: 55 |
||||
